External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: The PREVEND study

European Journal of Epidemiology

Volumn 27, Issue 1, 2012, Pages 47-52

  Abbasi, Ali ^a,b   Corpeleijn, Eva ^a   Peelen, Linda M ^b   Gansevoort, Ron T ^a   De Jong, Paul E ^a   Gans, Rijk O B ^a   Rathmann, Wolfgang ^c   Kowall, Bernd ^c   Meisinger, Christine ^d   Hillege, Hans L ^a   Stolk, Ronald P ^a   Navis, Gerjan ^a   Beulens, Joline W J ^b   Bakker, Stephan J L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

External validation; Older adults; Prediction model; Type 2 diabetes; Update

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; EXTERNAL VALIDITY; FAMILY HISTORY; FEMALE; FOLLOW UP; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NETHERLANDS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING; URIC ACID;

EID: 84857923360     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-011-9648-4     Document Type: Article

References (23)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53. (Pubitemid 38579764)
2. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374:1677-86.
3. Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28:2013-8. (Pubitemid 41060977)
4. Buijsse B, Simmons RK, Griffin SJ, Schulze MB. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev. 2011;33:46-62.
5. Stolk RP, Hutter I, Wittek RP. Population ageing research: a family of disciplines. Eur J Epidemiol. 2009;24:715-8.
6. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26:725-31. (Pubitemid 36929335)
7. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW. Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45-64 years. Ann Intern Med. 2009;150:741-51.
8. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middleaged adults: the framingham offspring study. Arch Intern Med. 2007;167:1068-74. (Pubitemid 46835795)
9. Balkau B, Lange C, Fezeu L, et al. Predicting diabetes: clinical, biological, and genetic approaches: data from the epidemiological study on the insulin resistance syndrome (DESIR). Diabetes Care. 2008;31:2056-61.
10. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev. 2000;16:164-71. (Pubitemid 30410271)
11. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011;343:d7163.
12. Vischer UM, Safar ME, Safar H, et al. Cardiometabolic determinants of mortality in a geriatric population: is there a 'reverse metabolic syndrome'? Diabetes Metab. 2009;35:108-14.
13. Weiss A, Boaz M, Beloosesky Y, Kornowski R, Grossman E. Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus. Diabet Med. 2009;26:253-9.
14. de Ruijter W, Westendorp RG, Assendelft WJ, et al. Use of framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2010;338:a3083.
15. Rathmann W, Kowall B, Heier M, et al. Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study. Diabet Med. 2010;27:1116-1123.
16. Rathmann W, Martin S, Haastert B, et al. KORA study group. performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA survey 2000. Arch Intern Med. 2005;165:436-41. (Pubitemid 40280200)
17. Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46:182-9. (Pubitemid 36343881)
18. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, et al. Albuminuria assessed from first-morning-void urine samples versus 24-h urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol. 2008;168:897-905.
19. Abbasi A, Corpeleijn E, Postmus D, et al. Plasma procalcitonin and risk of type 2 diabetes in the general population. Diabetologia. 2011;54:2463-5.
20. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128-38.
21. Janssen KJ, Moons KG, Kalkman CJ, Grobbee DE, Vergouwe Y. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol. 2008;61:76-86. (Pubitemid 350236700)
22. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605.
23. Vergouwe Y, Moons KG, Steyerberg EW. External validity of risk models: use of benchmark values to disentangle a case-mix effect from incorrect coefficients. Am J Epidemiol. 2010;172:971-80.